ImmuPharma plc (AIM: IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 5.40
+0.51 (10.43%)
Jan 30, 2025, 5:27 PM GMT+1
ImmuPharma Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -2.46 | -2.92 | -3.81 | -8.17 | -6.86 | -6.12 | Upgrade
|
| Depreciation & Amortization | -0.03 | 0.04 | 0.12 | 0.11 | 0.17 | 0.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.09 | 0.09 | 0 | - | - | - | Upgrade
|
| Stock-Based Compensation | -0.12 | 0.14 | 0.16 | 0.62 | 1.58 | 1.98 | Upgrade
|
| Other Operating Activities | 0.95 | 0.82 | 1.61 | 1.98 | 1.68 | 0.06 | Upgrade
|
| Change in Accounts Receivable | 0.16 | 0.26 | -0.3 | -0.27 | -0.01 | 0.18 | Upgrade
|
| Change in Accounts Payable | -0.18 | 0.21 | -0.13 | 0.9 | 0.11 | -0.41 | Upgrade
|
| Operating Cash Flow | -1.59 | -1.36 | -2.35 | -4.83 | -3.33 | -4.22 | Upgrade
|
| Capital Expenditures | - | - | -0.11 | -0.05 | -0.36 | -0.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.19 | 0.19 | - | - | - | - | Upgrade
|
| Investment in Securities | 1.48 | - | - | - | -0.25 | - | Upgrade
|
| Other Investing Activities | 0 | 0 | 0.03 | 0 | 0.04 | 0.01 | Upgrade
|
| Investing Cash Flow | 1.67 | 0.19 | -0.08 | -0.05 | -0.57 | -0.1 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 2.15 | - | Upgrade
|
| Total Debt Issued | - | - | - | - | 2.15 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0 | -0 | -0 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.72 | -0.84 | -0.09 | Upgrade
|
| Total Debt Repaid | 0 | - | - | -0.72 | -0.84 | -0.09 | Upgrade
|
| Net Debt Issued (Repaid) | 0 | - | - | -0.72 | 1.32 | -0.09 | Upgrade
|
| Issuance of Common Stock | 1.48 | 1.48 | 2.35 | 3.55 | 8 | 2.79 | Upgrade
|
| Other Financing Activities | -0.65 | -0.76 | -0.8 | -2.12 | -0.95 | -2.37 | Upgrade
|
| Financing Cash Flow | 0.83 | 0.72 | 1.55 | 0.7 | 8.37 | 0.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.04 | -0.01 | -0.1 | -0.03 | 0.03 | 0.45 | Upgrade
|
| Net Cash Flow | 0.87 | -0.46 | -0.98 | -4.21 | 4.5 | -3.55 | Upgrade
|
| Free Cash Flow | -1.59 | -1.36 | -2.45 | -4.88 | -3.69 | -4.33 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -4126.83% | -2912.91% | -5554.70% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Cash Interest Paid | 0 | 0 | 0 | 0.12 | 0.06 | 0 | Upgrade
|
| Cash Income Tax Paid | - | -0.96 | -0.88 | -0.39 | -0.61 | -0.75 | Upgrade
|
| Levered Free Cash Flow | -1.41 | -0.99 | -1.83 | -1.79 | -1.48 | -3.49 | Upgrade
|
| Unlevered Free Cash Flow | -1.41 | -0.99 | -1.83 | -1.71 | -1.34 | -3.49 | Upgrade
|
| Change in Net Working Capital | -0.32 | -0.75 | 0.11 | -0.83 | -0.77 | 1.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.